Gebro Pharma raises its turnover to 112 million in 2025, up 2%
Gebro Pharma has concluded the 2025 fiscal year with a turnover of 112 million euros, representing a 2% increase compared to the previous year, as the company reported this Thursday in a statement.The pharmaceutical company indicated that it closed the year "confirming positive evolution, sustaining its level of activity and...
5 minutos